2021 UCB U.S. Sustainable Access and Pricing Transparency Report
At UCB, we have a fundamental commitment to enabling people living with severe diseases, their caregivers, and their families to live the lives they want. We innovate to deliver unique outcomes that help specific patients achieve their life goals, to create the best individual experience for them, and to ensure access for all patients who need our solutions in a way which is viable for patients, society and UCB.
Following our 2021 Integrated Annual Report , the first UCB U.S. Sustainable Access and Pricing Transparency report highlights for stakeholders how UCB accounts for the value of its medicines and opportunities to advocate for policy reforms to build a sustainable U.S. healthcare system.
This report includes:
How we deliver affordable access and account for value, including our pricing
Our actions aimed at sustainable access in the U.S. healthcare system
Policy reform opportunities to build a sustainable system together
For UCB, sustainable access is ensuring access to all who need our solutions in a way which is viable.
We are committed to scientific innovation and the discovery, development, and delivery of differentiated solutions that provide measurable value to patients — improving their lives now and in the future.
To deliver sustainable, affordable access, UCB strives to ensure our prices are sustainable for patients and society and are aligned with the value they provide. We also offer access programs to support patients, and we partner with stakeholders in ways that benefit society.
We are committed to working across the healthcare ecosystem – with patients, payers, providers, caregivers, and policymakers, to explore a broad range of value and support smarter spending in the healthcare ecosystem, while ensuring that patients are able to access and afford the next generation of transformative medicines.